# Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder

> **NCT07217054** · — · RECRUITING · sponsor: **CND Life Sciences** · enrollment: 40 (estimated)

## Conditions studied

- PARKINSON DISEASE (Disorder)
- Parkinson
- Parkinson s Disease
- Parkinson Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07217054
- **Lead sponsor:** CND Life Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-04
- **Primary completion:** 2028-10
- **Final completion:** 2029-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07217054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07217054, "Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT07217054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*